LINEZOLID IN THE TREATMENT OF SUBJECTS WITH NOSOCOMIAL PNEUMONIA PROVEN TO BE DUE TO METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS

INTERVENTION: Pharmaceutical Form: Solution for infusion INN or Proposed INN: Linezolid Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 600‐ Pharmaceutical Form: Powder and solvent for solution for infusion INN or Proposed INN: Vancomycin CAS Number: 1404‐93‐9 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 15‐ CONDITION: Nosocomial Pneumoniae due to MRSA ; MedDRA version: 6.1 Level: PT Classification code 10035734 PRIMARY OUTCOME: Main Objective: Primary end point(s): Secondary Objective: INCLUSION CRITERIA: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18‐64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range